World News
Politics
Stock
Investing
Editor’s Pick

Completion of Non-Renounceable Pro-Rata Entitlement Offer

by admin September 15, 2025

September 15, 2025

Carbonxt Group (CG1:AU) has announced Completion of Non-Renounceable Pro-Rata Entitlement Offer

Download the PDF here.

This post appeared first on investingnews.com

previous post

Kash Patel’s false start on Charlie Kirk killer draws scrutiny, but FBI nabbed suspect in the end

next post

Significant Enlargement of Exploration Program

Related Posts

Mike Maloney: Gold, Silver Bull Run in Final...

November 15, 2025

Dana Samuelson: Gold, Silver in Global Bank Run,...

November 15, 2025

Gold’s Long Game: New Orleans Panelists See More...

November 15, 2025

Editor’s Picks: Gold and Silver Prices Rise as...

November 15, 2025

Top 5 Canadian Mining Stocks This Week: Adex...

November 15, 2025

Realigning Portfolio Allocation with Nicholas Mersch

November 14, 2025

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

Your name
Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Recent Posts

More than 1,000 Starbucks workers strike at 65 stores on Red Cup Day

November 15, 2025
DAVID MARCUS: How Chuck Schumer finally reaped the whirlwind

November 15, 2025
Trump to ask DOJ to investigate Epstein ties to Democrats, banks

November 15, 2025
GREGG JARRETT: Comey’s Russian hoax is a reminder of how he is similar to Nixon

November 15, 2025
Republicans, health experts push back on Democrats’ Medicaid ‘scare tactics’

November 15, 2025

About us
Contact us
Privacy Policy
Terms & Conditions

Copyright © 2025 timeandsalesreporter.com | All Rights Reserved

World News
Politics
Stock
Investing
Editor’s Pick

Read alsox

Making Medicine Cost More Won’t Make America Healthy...

April 14, 2025

Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy...

May 15, 2025

Trump Punishes Large Law Firm for Representing His...

February 26, 2025